|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBOOKCENTRAL_on1045629884 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
180724s2018 enk ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d YDX
|d MERUC
|d N$T
|d OCLCF
|d UKAHL
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 1046109831
|
| 020 |
|
|
|a 9781910079607
|q (electronic bk.)
|
| 020 |
|
|
|a 191007960X
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000070393013
|
| 035 |
|
|
|a (OCoLC)1045629884
|z (OCoLC)1046109831
|
| 050 |
|
4 |
|a RC86.9
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.028076
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Jeyanathan, Jeyasankar,
|e author.
|
| 245 |
1 |
0 |
|a Viva and structured oral examinations in intensive care medicine /
|c Jeyasankar Jeyanathan, Chris Johnson, James Haslam.
|
| 264 |
|
1 |
|a Shrewsbury, UK :
|b Tfm Publishing Ltd,
|c 2018.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Viva and Structured Oral Examinations in Intensive Care Medicine; Title Page; Copyright; Contents; Preface; Contributors; Abbreviations; Dedication; SET1; Post-cardiac arrest care; 1) What is the mortality following cardiac arrest?; 2) What is the post-cardiac arrest syndrome?; 3) What are the management priorities post-cardiac arrest?; General management; Specific management; 4) Should we be cooling patients post-cardiac arrest?; 5) How can we prognosticate patients post-cardiac arrest on intensive care?; Summary of Key Points; References; ARDS and prone ventilation; 1) What is ARDS?
|
| 505 |
8 |
|
|a 2) What are the risk factors for the development of ARDS?3) What is the pathophysiology of ARDS?; Diffuse alveolar damage; Lung capillary endothelial injury; 4) What investigations would you do in someone you suspected had ARDS?; Bedside; Laboratory; Radiological; Special; 5); A) What are the management principles in ARDS?; General; Pharmacological; Ventilatory strategy; Management of refractory hypoxia; B) What is the evidence for prone ventilation in ARDS?; C) What are the possible complications of prone ventilation and how can they be mitigated against?
|
| 505 |
8 |
|
|a D) Describe the postulated mechanisms by which prone positioning aids oxygen exchange in ARDS. Summary of Key Points; References; Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura; 1) What is haemolytic uraemic syndrome (HUS)?; 2) List some laboratory markers of haemolysis.; 3); A) How might you diagnose an E. coli infection?; B) What other pathogens may be causative?; 4); A) How does HUS differ from thrombotic thrombocytopenic purpura (TTP)?; B) What laboratory findings can help differentiate HUS and TTP from disseminated intravascular coagulation (DIC)?; 5)
|
| 505 |
8 |
|
|a A) Outline the treatment priorities for HUS. B) Discuss the role of plasma exchange.; Summary of Key Points; References; Tricyclic antidepressant overdose; 1) What are tricyclic antidepressants and what is their mechanism of action?; 2) What are the features of tricyclic antidepressant overdose?; Clinical features; Biochemical features; Electrocardiographic features; 3) How would you manage tricyclic antidepressant overdose?; 4) What are the clinical features of serotonin syndrome?; Clinical features; 5) How would you manage serotonin syndrome?; Summary of Key Points; References
|
| 505 |
8 |
|
|a Statistics, evidence and research1) What do you understand by the terms 'level of evidence' and 'grade of recommendation'?; Levels of evidence; Grade of recommendation; 2) What is a meta-analysis?; 3) What are the phases of clinical trials?; 4) What types of data are you aware of?; 5) What is the difference between sensitivity and specificity?; 6) What do you understand by the term 'p-value'?; 7) What are confidence intervals?; 8) What is the 'Student's t-test' used for?; 9) How does 'analysis of variance' (ANOVA) differ from the 'Student's t-test'?; Summary of Key Points; References
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Critical care medicine
|v Study guides.
|
| 650 |
|
6 |
|a Soins intensifs
|v Guides de l'étudiant.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Critical care medicine
|2 fast
|
| 655 |
|
7 |
|a examination study guides.
|2 aat
|
| 655 |
|
7 |
|a Study guides
|2 fast
|
| 655 |
|
7 |
|a Study guides.
|2 lcgft
|
| 655 |
|
7 |
|a Guides de l'étudiant.
|2 rvmgf
|
| 700 |
1 |
|
|a Johnson, Chris,
|e author.
|
| 700 |
1 |
|
|a Haslam, James,
|e author.
|
| 758 |
|
|
|i has work:
|a Viva and structured oral examinations in intensive care medicine (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGdWGp6VXdcBgB4XRThFgC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5471900
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH35099541
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH34846488
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5471900
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1854981
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15610773
|
| 994 |
|
|
|a 92
|b IZTAP
|
